Healthcare and Medicine Consultancy Infrastructure and construction

Kyowa Kirin Biologics Tender

🏛️ KYOWA KIRIN
📄 Tender ID: 506536142 📅 Published: 25 Jul 2024

📋 Tender Overview

Scope :
Kyowa Kirin will build its first North American biologics manufacturing facility in North Carolina, US by 2027.
Kyowa Kirin, a pharmaceutical company based in Japan, will build a new biologics manufacturing facility in Sanford, North Carolina, expanding its worldwide manufacturing presence in North America.

The facility will produce cutting-edge biologic therapies, such as next-generation antibodies, for the company’s upcoming clinical trials and future commercial purposes. It will help in establishing more robust and efficient supply chains that can better withstand changing global dynamics.

Kyowa Kirin approved an investment of up to $530m to build the facility in June 2024. Construction will commence in the second half of 2024, with the facility expected to be fully operational by 2027. The facility will generate 102 new jobs.
Location

The facility will be situated within the Helix Innovation Park at the Brickyard in northern Lee County in Sanford. The innovation park is an 895-acre (362 hectare) industrial park designed for advanced manufacturing and life sciences, owned by Helix Ventures and Trustwell Group.

75 acres of land was acquired by the company within the innovation park for the development of the facility.

The North Carolina Department of Commerce led the state’s assistance to the company throughout its site evaluation and decision-making process. The Economic Development Partnership of North Carolina (EDPNC) collaborated with state and local partners, including the North Carolina Biotechnology Center to help with site selection for the project.

The location offers connectivity to the state’s life sciences industry and workforce development resources. The facility will benefit from proximity to North Carolina’s life sciences hub, the Research Triangle Park region and the expertise of renowned universities and community colleges.
Kyowa Kirin biologics manufacturing plant details

The state-of-the-art manufacturing facility will have a gross floor area of 171,700ft² (15,951m²). It will house two bioreactors that will expedite the development and manufacturing of novel biological therapies to advance the clinical pipeline for patients with rare and serious diseases.

The facility will be designed to scale alongside the company’s existing Takasaki Plant in Japan, facilitating technology transfer between the two sites and increasing production capacity.

The master plan offers flexibility for future growth and new capabilities. Additional land has been secured for potential future expansions in line with the company’s growing needs as its pipeline programmes progress.
Financing details and partners involved

The project is expected to receive performance-based state and local incentives amounting to $10m over 12 years.

It will also receive support from a Job Development Investment Grant (JDIG) approved by the state’s Economic Investment Committee in February 2024.

The North Carolina Departm

🔍 Key Information

📄
Tender Reference No.
506536142
📅
Publication Date
25 Jul 2024
💰
Estimated Value
USD 530000000
🌐
Sector
Healthcare and Medicine
📅
Deadline
31 Dec 2027
📝
Notice Type
Projects
📍
Location
United states
📑
Contract Duration
3 Years 5 Months 6 Days

📁 Documents & Downloads

No documents found

🏷️ CPV

No CPV found

Need help with this bid?

Our bid experts can help you find, evaluate & win more tenders.

🎧 Talk to Bid Expert
🕒 Submission deadline
408
days remaining · 31 Dec 2027
🔔 Set Alert

🧭 Quick Facts

Authority KYOWA KIRIN
Country United states
State / UT N/A
Tender Type Project Information
Currency USD
Similar Tenders
Loading similar tenders…